ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 189 filers reported holding ACORDA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,000 | 0.0% | 2,674 | +206.7% | 0.00% | – |
| Q2 2019 | $7,000 | -41.7% | 872 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $12,000 | -93.6% | 872 | -92.7% | 0.00% | -94.1% |
| Q4 2018 | $188,000 | +6.8% | 12,018 | +34.7% | 0.02% | +30.8% |
| Q3 2018 | $176,000 | -99.3% | 8,921 | +901.2% | 0.01% | +550.0% |
| Q2 2018 | $25,572,000 | +88079.3% | 891 | -25.0% | 0.00% | -33.3% |
| Q1 2018 | $29,000 | -27.5% | 1,188 | -35.3% | 0.00% | 0.0% |
| Q4 2017 | $40,000 | +110.5% | 1,837 | +131.9% | 0.00% | +50.0% |
| Q3 2017 | $19,000 | +18.8% | 792 | -0.1% | 0.00% | 0.0% |
| Q2 2017 | $16,000 | +433.3% | 793 | +432.2% | 0.00% | – |
| Q1 2017 | $3,000 | -94.8% | 149 | -93.4% | 0.00% | -100.0% |
| Q2 2016 | $58,000 | – | 2,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |